STOCK TITAN

Perrigo insider trade: 5.2K shares sold, 2.2K RSUs granted

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Perrigo Company plc (PRGO) – Form 4 insider filing: Executive Vice President & President of CSCI, Roberto Khoury, reported two transactions dated 8 July 2025.

  • Disposition: Khoury disposed of 5,205 ordinary shares (Table I, coded “D”). No price information was supplied in the excerpt.
  • Acquisition (equity award): He received 2,211 Restricted Stock Units (RSUs) (Table II, coded “A”). Each RSU converts to one ordinary share and vests in three equal annual instalments beginning 8 July 2026.

Following the transactions, Khoury directly owns the newly granted 2,211 RSUs; the filing does not disclose his remaining ownership of ordinary shares beyond the figures above. The activity is routine executive equity compensation combined with a modest share sale, providing limited insight into fundamental performance but useful for monitoring insider sentiment and potential dilution.

Positive

  • Equity award of 2,211 RSUs incentivises the EVP over a multi-year horizon, aligning management interests with shareholders.

Negative

  • Sale of 5,205 ordinary shares reduces the executive’s immediate stake and could be viewed as mild insider selling pressure.

Insights

TL;DR: Routine equity grant offset by small share sale; neutral impact.

The Form 4 shows standard executive compensation—2,211 RSUs—with a simultaneous sale of 5,205 shares. The RSU grant aligns incentives over a three-year vesting period, signalling retention intent. However, the share sale slightly reduces direct ownership and may be interpreted as modest insider profit-taking. Without pricing data or broader context, the net effect on investor sentiment is minimal. I classify the filing as informational, not materially affecting valuation.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Khoury Roberto

(Last) (First) (Middle)
C/O PERRIGO COMPANY PLC
515 EASTERN AVENUE

(Street)
ALLEGAN MI 49010

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
PERRIGO Co plc [ PRGO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP and President of CSCI
3. Date of Earliest Transaction (Month/Day/Year)
07/08/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Ordinary Shares 5,205 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 07/08/2025 A 2,211 (2) (2) Ordinary Shares 2,211 (1) 2,211 D
Explanation of Responses:
1. Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.
2. Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 8 July 2026.
Remarks:
s/ Diana Witt, attorney-in-fact for Mr. Roberto Khoury 07/10/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity was reported for PRGO on 8 July 2025?

EVP Roberto Khoury sold 5,205 shares and received 2,211 RSUs.

How many Perrigo shares did Roberto Khoury acquire through equity awards?

He acquired 2,211 Restricted Stock Units, each convertible to one ordinary share.

When do the newly granted RSUs to PRGO's EVP vest?

The RSUs vest in three equal annual instalments starting 8 July 2026.

Did the filing disclose the sale price for the 5,205 shares?

No. The excerpted Form 4 does not list a transaction price.

What is the significance of a Form 4 filing for investors?

Form 4s disclose insider trades, offering insight into management’s sentiment and potential alignment with shareholder interests.
Perrigo Co Plc

NYSE:PRGO

PRGO Rankings

PRGO Latest News

PRGO Latest SEC Filings

PRGO Stock Data

2.00B
137.02M
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
Ireland
DUBLIN 2